1.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: P100103, NCT01431430
|
|
2.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 19 to 90 Sponsor: Other Protocol IDs: CLIN-007-12S, Pro00019745, NCT01759771
|
|
3.
|
Phase: Phase III, Phase II Type: Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: s55283, 2013-001064-27, NCT01809171
|
|
4.
|
Phase: Phase III Type: Prevention Status: Active Age: 60 and over Sponsor: NCI, Other Protocol IDs: 2009P-001217, NCT01169259
|
|
5.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: S480/209, 2009-012049-46, NCT01264874
|
|
6.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VITACAL, VA 2010/12, 2010-023459-27, NCT01480869
|
|
7.
|
Phase: Phase III Type: Natural history/Epidemiology Status: Active Age: 18 and over Sponsor: Other Protocol IDs: D-HEM, NCT01518959
|
|
8.
|
Phase: Phase III Type: Prevention Status: Active Age: 55 and over Sponsor: Other Protocol IDs: TIPS-3, NCT01646437
|
|
9.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 2012LRDVDCM, 2012-002125-30, NCT01748448
|
|
10.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: SOR504110CTIL, NCT01181193
|
|
11.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 200806, NCT01425476
|
|
12.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 200807-001, NCT01769625
|
|
13.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-0580-B, NCT00744549
|
|
14.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-0604-CE, NCT00844792
|
|
15.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 to 50 Sponsor: NCI, Other Protocol IDs: CDR0000668698, S0812, U10CA032102, SWOG-S0812, NCT01097278
|
|
16.
|
Phase: Phase II Type: Prevention Status: Active Age: 18 to 55 Sponsor: Other Protocol IDs: DR-002-1373, NCT01747720
|
|
17.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: I 128308, NCI-2009-01530, RPCI-I-128308, NCT00887432
|
|
18.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CASE2210, NCI-2011-01280, NCT01403103
|
|
19.
|
Phase: No phase specified Type: Supportive care Status: Active Age: 18 to 88 Sponsor: Other Protocol IDs: 34834, NCT01419730
|
|
20.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Approved-not yet active Age: 60 and over Sponsor: Other Protocol IDs: FIND, NCT01463813
|
|
21.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Active Age: 18 to 64 Sponsor: NCI, Other Protocol IDs: I 203111, NCI-2011-03232, NCT01561989
|
|
22.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 and over Sponsor: Other Protocol IDs: STU00064898, NCT01744821
|
|
23.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LS1293, NCI-2013-00037, NCT01787409
|
|
24.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 101813, NCT01816555
|